Pancreatic Cancer Trial, Recruiting (NCT06764134)

Pancreatic Cancer Trial, Recruiting NCT06764134 Sponsor: University Hospital Heidelberg Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06764134 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older.
You are able to understand what the study involves and what it means to take part.
You are willing and able to sign a written consent form agreeing to participate.
You are already scheduled to have surgery to remove part of your pancreas (the left side), either through small keyhole incisions or open surgery, for any medical reason, and this may also include removal of the spleen and/or left adrenal gland.

Who may not be able to join:

You are unable to follow the study procedures or attend the required follow-up appointments.
Your surgery involves removing additional organs beyond the left adrenal gland.
You have had surgery on your pancreas before.
There are concerns that you may not be able to follow the study plan as required (confirm with trial site).
You are currently taking part in another clinical trial that could affect this study's procedures or results.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06764134

Sponsor: University Hospital Heidelberg

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatic Cancer

More information: https://clinicaltrials.gov/study/NCT06764134

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older.
You are able to understand what the study involves and what it means to take part.
You are willing and able to sign a written consent form agreeing to participate.
You are already scheduled to have surgery to remove part of your pancreas (the left side), either through small keyhole incisions or open surgery, for any medical reason, and this may also include removal of the spleen and/or left adrenal gland.

Who may not be able to join:

You are unable to follow the study procedures or attend the required follow-up appointments.
Your surgery involves removing additional organs beyond the left adrenal gland.
You have had surgery on your pancreas before.
There are concerns that you may not be able to follow the study plan as required (confirm with trial site).
You are currently taking part in another clinical trial that could affect this study's procedures or results.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital Heidelberg

Registry

ClinicalTrials.gov

Start date

1 November 2024

Est. completion

31 October 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Rate of Clinically Relevant Postoperative Pancreatic Fistula (POPF)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov